OGN

Dopo l'orario di chiusura: 7.03 0.01 +0.14%

Organon Co (OGN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Storia dei dividendi

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Organon Co Stock (OGN) Company Profile

Healthcare (1131)

551-430-6000

30 HUDSON STREET, JERSEY CITY

Prossima data di guadagno

Ultimi documenti SEC

OGN's Discussions on Twitter

Confronta OGN con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
OGN Organon Co	7.02	1.86B	6.28B	700.00M	537.00M	2.6922
LLY Lilly Eli Co	1,062.19	919.64B	59.42B	18.41B	6.44B	20.22
JNJ Johnson Johnson	214.17	509.76B	92.15B	25.12B	20.46B	10.36
ABBV Abbvie Inc	227.45	394.69B	59.64B	2.36B	19.68B	1.3253
NVS Novartis Ag Adr	135.19	254.37B	54.45B	14.42B	17.15B	7.333
MRK Merck Co Inc	100.26	248.95B	63.90B	19.05B	13.05B	7.5596

Organon Co Stock (OGN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-09	Iniziato	Barclays	Underweight
2025-10-27	Downgrade	Piper Sandler	Overweight → Underweight
2025-05-02	Downgrade	Evercore ISI	Outperform → In-line
2024-09-06	Downgrade	JP Morgan	Neutral → Underweight
2023-11-03	Downgrade	Goldman	Buy → Neutral
2023-09-21	Iniziato	Barclays	Overweight
2023-03-16	Iniziato	Raymond James	Outperform
2022-10-14	Downgrade	BofA Securities	Neutral → Underperform
2022-09-06	Aggiornamento	Piper Sandler	Neutral → Overweight
2022-08-05	Downgrade	BofA Securities	Buy → Neutral
2022-04-27	Iniziato	Goldman	Buy
2022-04-06	Ripresa	Morgan Stanley	Equal-Weight
2021-10-07	Iniziato	Piper Sandler	Neutral
2021-09-01	Iniziato	BofA Securities	Buy
2021-07-22	Iniziato	Citigroup	Buy
2021-06-15	Iniziato	JP Morgan	Neutral
2021-06-11	Iniziato	Morgan Stanley	Equal-Weight
2021-06-10	Iniziato	Evercore ISI	Outperform

Mostra tutto

Organon Co Borsa (OGN) Ultime notizie

Organon Co Azioni (OGN) Dati Finanziari

Organon Co (OGN)

Organon Co Stock (OGN) Company Profile

Confronta OGN con altri titoli

Organon Co Stock (OGN) Upgrades & Downgrades

Organon Co Borsa (OGN) Ultime notizie

Organon Launches Phase 3 Study on Tapinarof Cream for Atopic Dermatitis in Infants - TipRanks

Why Analysts See Organon’s Story Shifting Amid Governance Concerns And Lower Valuations - Yahoo Finance UK

Is Trending Stock Organon & Co. (OGN) a Buy Now? - Yahoo Finance

Organon & Co. $OGN Stake Lessened by Globeflex Capital L P - MarketBeat

Organon Shares Under Pressure Following Critical Analyst Review - AD HOC NEWS

Can Organon’s Steep 2025 Share Price Slide Signal a Long Term Opportunity? - simplywall.st

Organon pushes bold women’s health agenda at WHX Leaders’ Summit in Accra - MyJoyOnline

Les billets sont maintenant en vente pour Importance Vitale : sommet national sur la santé des femmes - GlobeNewswire Inc.

Why Organon (OGN) shares are trading lower today - MSN

New York State Common Retirement Fund Sells 353,330 Shares of Organon & Co. $OGN - MarketBeat

Understanding Momentum Shifts in (OGN) - news.stocktradersdaily.com

Investors in Organon & Co. (OGN): Protect Your RightsContact Levi & Korsinsky Before July 22, 2025 - ACCESS Newswire

Organon & Co. (NYSE:OGN) Stock Rating Upgraded by Barclays - MarketBeat

Organon & Co. $OGN Shares Bought by Cerity Partners LLC - MarketBeat

WHX Africa Leaders Summit: Organon Unveils Multi-Sector Approach to Women’s Health in Africa - News Ghana

Barclays Initiates Coverage of Organon (OGN) with Underweight Recommendation - Nasdaq

Why Organon (OGN) Shares Are Trading Lower Today - The Globe and Mail

Organon (OGN) Receives New Coverage with 'Underweight' Rating fr - GuruFocus

Barclays Initiates Coverage on Organon & Co. (NYSE:OGN) - MarketBeat

Norges Bank Takes $19.78 Million Position in Organon & Co. $OGN - MarketBeat

Organon initiated with an Underweight at Barclays - TipRanks

American Century Companies Inc. Grows Position in Organon & Co. $OGN - MarketBeat

What analysts say about Organon Co stockFederal Reserve Announcements & Outstanding Growth Strategies - earlytimes.in

A Closer Look At Organon & Co.'s (NYSE:OGN) Impressive ROE - 富途牛牛

Can Organon (OGN) Turn Rising Investor Attention Into a Durable Reboot of Its Core Story? - simplywall.st

Organon & Co. (OGN) Stock Forecasts - Yahoo! Finance Canada

Co. (7XP) stock compared to peersPortfolio Update Report & Precise Buy Zone Identification - Newser

Organon & Co. $OGN Shares Acquired by Brandes Investment Partners LP - MarketBeat

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - MSN

Russell Investments Group Ltd. Has $15.96 Million Stock Position in Organon & Co. $OGN - MarketBeat

Can Organon’s (OGN) Biosimilar Push Transform Its Competitive Position in US Oncology? - Yahoo Finance

A Look at Organon's Valuation Following FDA Approval of First US Pertuzumab Biosimilar - Yahoo Finance

Is Organon’s Recent 14% Price Jump Justified After Women’s Health Partnership News? - Yahoo Finance

What analysts say about Organon Co 7XP stockShort Interest Overview & Grow Steadily With Our Wealth Roadmap - earlytimes.in

Organon (OGN): Buy, Sell, or Hold Post Q3 Earnings? - The Globe and Mail

Grantham Mayo Van Otterloo & Co. LLC Buys 108,429 Shares of Organon & Co. $OGN - MarketBeat

Avoiding Lag: Real-Time Signals in (OGN) Movement - news.stocktradersdaily.com

Organon (OGN): Exploring Valuation Following FDA Approval of First US Pertuzumab Biosimilar - simplywall.st

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review

Organon & Co. $OGN Shares Sold by Envestnet Asset Management Inc. - MarketBeat

Organon & Co. (OGN) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review

Creative Planning Buys 97,429 Shares of Organon & Co. $OGN - MarketBeat

Advisors Asset Management Inc. Sells 64,625 Shares of Organon & Co. $OGN - MarketBeat

Is Organon Co 7XP a good long term investmentLong-Term Investment Plans & High Yield Investment Portfolio - earlytimes.in

Organon & Co. $OGN Shares Sold by Geode Capital Management LLC - MarketBeat

Q3 Rundown: Organon (NYSE:OGN) Vs Other Branded Pharmaceuticals Stocks - The Globe and Mail

EXTENDED CLASS PERIOD: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit (PR Newswire) - Aktiellt

TUESDAY INVESTOR DEADLINE: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit (PR Newswire) - Aktiellt

Congressional Trading Report: Sen. Gary C Peters Sold Over $1K In Organon Stock - Sahm

Organon (NYSE: OGN) leaders to speak at Piper Sandler 37th Annual Healthcare Conference - Stock Titan

Organon & Co.Gary C. Peters Congressional Trade on Jul. 10, 2025 - Quiver Quantitative

Organon Co Azioni (OGN) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a OGN